4-HO-MPMI
Chemical compound

4-HO-MPMI, also known as 4-hydroxy-N-methyl-(α,N-trimethylene)tryptamine or as lucigenol, is a psychedelic drug of the pyrrolidinylmethylindole and cyclized tryptamine families.
01Pharmacology
Pharmacodynamics
The affinity (Ki) of 4-HO-MPMI for the serotonin 5-HT2A receptor has been found to be 13 nM. It produces psychedelic-appropriate responding in animal tests with similar potency as DOI. The drug has two enantiomers, with only the (R)-enantiomer being active.
02Chemistry
Analogues
Analogues of 4-HO-MPMI include MPMI, 5-MeO-MPMI, 5F-MPMI, CP-135,807, 4-HO-McPeT, 4-HO-pyr-T, and SN-22, among others.
03History
4-HO-MPMI was developed by the team led by David E. Nichols from Purdue University in the late 1990s.
04Society and culture
Sources and credits
This article is adapted from the Wikipedia article “4-HO-MPMI”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Images, from Wikimedia Commons:
- Lucigenol (4-HO-MPMI).svg by AlyInWikiWonderland, Public domain
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.